BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34714283)

  • 1. Human Recombinant Arginase I [HuArgI(Co)-PEG5000]-Induced Arginine Depletion Inhibits Pancreatic Cancer Cell Migration and Invasion Through Autophagy.
    El-Mais N; Fakhoury I; Al Haddad M; Nohra S; Abi-Habib R; El-Sibai M
    Pancreas; 2021 Sep; 50(8):1187-1194. PubMed ID: 34714283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Recombinant Arginase I [HuArgI (Co)-PEG5000]-Induced Arginine Depletion Inhibits Colorectal Cancer Cell Migration and Invasion.
    Al-Koussa H; Al-Haddad M; Abi-Habib R; El-Sibai M
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells.
    Khoury O; Ghazale N; Stone E; El-Sibai M; Frankel AE; Abi-Habib RJ
    J Neurooncol; 2015 Mar; 122(1):75-85. PubMed ID: 25567351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human recombinant arginase I [HuArgI (Co)-PEG5000]-induced arginine depletion inhibits ovarian cancer cell adhesion and migration through autophagy-mediated inhibition of RhoA.
    El-Mais N; Fakhoury I; Abdellatef S; Abi-Habib R; El-Sibai M
    J Ovarian Res; 2021 Jan; 14(1):13. PubMed ID: 33423701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of autophagy following [HuArgI (Co)-PEG5000]-induced arginine deprivation mediates cell death in colon cancer cells.
    Swayden M; Bekdash A; Fakhoury I; El-Atat O; Borjac-Natour J; El-Sibai M; Abi-Habib RJ
    Hum Cell; 2021 Jan; 34(1):152-164. PubMed ID: 32979152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HuArgI (co)-PEG5000]-induced arginine deprivation leads to autophagy dependent cell death in pancreatic cancer cells.
    Khalil N; Abi-Habib RJ
    Invest New Drugs; 2020 Oct; 38(5):1236-1246. PubMed ID: 31823161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells.
    Tanios R; Bekdash A; Kassab E; Stone E; Georgiou G; Frankel AE; Abi-Habib RJ
    Leuk Res; 2013 Nov; 37(11):1565-71. PubMed ID: 24018014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxicity of human recombinant arginase I (Co)-PEG5000 in the presence of supplemental L-citrulline is dependent on decreased argininosuccinate synthetase expression in human cells.
    Agrawal V; Woo JH; Mauldin JP; Jo C; Stone EM; Georgiou G; Frankel AE
    Anticancer Drugs; 2012 Jan; 23(1):51-64. PubMed ID: 21955999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxicity of [HuArgI (co)-PEG5000]-induced arginine deprivation to ovarian Cancer cells is autophagy dependent.
    Nasreddine G; El-Sibai M; Abi-Habib RJ
    Invest New Drugs; 2020 Feb; 38(1):10-19. PubMed ID: 30887252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineered arginase I increases caspase-3 expression of hepatocellular and pancreatic carcinoma cells despite induction of argininosuccinate synthetase-1.
    Glazer ES; Kaluarachchi WD; Massey KL; Zhu C; Curley SA
    Surgery; 2010 Aug; 148(2):310-8. PubMed ID: 20466402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
    Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
    Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking autophagy enhanced leukemia cell death induced by recombinant human arginase.
    Li Y; Zeng X; Wang S; Fan J; Wang Z; Song P; Mei X; Ju D
    Tumour Biol; 2016 May; 37(5):6627-35. PubMed ID: 26643895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells.
    Zeng X; Li Y; Fan J; Zhao H; Xian Z; Sun Y; Wang Z; Wang S; Zhang G; Ju D
    Cell Death Dis; 2013 Oct; 4(10):e840. PubMed ID: 24113174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant
    Chung SF; Kim CF; Chow HY; Chong HC; Tam SY; Leung YC; Lo WH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysophosphatidic acid stimulates activation of focal adhesion kinase and paxillin and promotes cell motility, via LPA1-3, in human pancreatic cancer.
    Liao Y; Mu G; Zhang L; Zhou W; Zhang J; Yu H
    Dig Dis Sci; 2013 Dec; 58(12):3524-33. PubMed ID: 24061591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
    Hassabo AA; Abdelraof M; Allam RM
    Int J Biol Macromol; 2023 Jan; 224():634-645. PubMed ID: 36302487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic 8-hydroxydeoxyguanosine inhibited metastasis of pancreatic cancer through concerted inhibitions of ERM and Rho-GTPase.
    Park JM; Han YM; Jeong M; Chung MH; Kwon CI; Ko KH; Hahm KB
    Free Radic Biol Med; 2017 Sep; 110():151-161. PubMed ID: 28602912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical safety and antitumor activity of the arginine-degrading therapeutic enzyme pegzilarginase, a PEGylated, cobalt-substituted recombinant human arginase 1.
    Agnello G; Alters SE; Rowlinson SW
    Transl Res; 2020 Mar; 217():11-22. PubMed ID: 31954097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor.
    Shen W; Zhang X; Fu X; Fan J; Luan J; Cao Z; Yang P; Xu Z; Ju D
    Cell Death Dis; 2017 Mar; 8(3):e2720. PubMed ID: 28358368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockage of SLC31A1-dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death.
    Yu Z; Zhou R; Zhao Y; Pan Y; Liang H; Zhang JS; Tai S; Jin L; Teng CB
    Cell Prolif; 2019 Mar; 52(2):e12568. PubMed ID: 30706544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.